Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation

Journal of Vascular Surgery

Volumn 49, Issue 5, 2009, Pages 1289-1295

  Edlin, Rachel S ^a,b   Tsai, Shirling ^a   Yamanouchi, Dai ^c   Wang, Chunjie ^c   Liu, Bo ^c   Kent, K Craig ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD3 PROTEIN; SMALL INTERFERING RNA; THYMIDINE;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMORAL ARTERY; GENE TRANSFER; HUMAN; HUMAN TISSUE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESTENOSIS; SMOOTH MUSCLE FIBER;

ANGIOPLASTY; APOPTOSIS; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; ATHEROSCLEROSIS; CELL PROLIFERATION; CELLS, CULTURED; CONSTRICTION, PATHOLOGIC; FEMORAL ARTERY; HUMANS; HYPERPLASIA; MYOCYTES, SMOOTH MUSCLE; RECURRENCE; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; STENTS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 65249093597     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.11.096     Document Type: Article

References (29)

1. Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
2. Schillinger M., Sabeti S., Dick P., Amighi J., Mlekusch W., Schlager O., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007) 2745-2749
3. Bauriedel G., Schluckebier S., Hutter R., Welsch U., Kandolf R., Luderitz B., et al. Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. Arterioscler Thromb Vasc Biol 18 (1998) 1132-1139
4. Nikol S., Murakami N., Pickering J.G., Kearney M., Leclerc G., Hofling B., et al. Differential expression of nonmuscle myosin II isoforms in human atherosclerotic plaque. Atherosclerosis 130 (1997) 71-85
5. Hao H., Gabbiani G., and Bochaton-Piallat M.-L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 23 (2003) 1510-1520
6. Isner J.M. Vascular remodeling. Honey, I think I shrunk the artery. Circulation 89 (1994) 2937-2941
7. Kingston P.A., Sinha S., David A., Castro M.G., Lowenstein P.R., and Heagerty A.M. Adenovirus-mediated gene transfer of a secreted transforming growth factor-β type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Circulation 104 (2001) 2595-2601
8. Nikol S., Isner J., Pickering J., Kearney M., Leclerc G., and Weir L. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 90 (1992) 1582-1592
9. Bauriedel G., Kandolf R., Schluckebier S., and Welsch U. Ultrastructural characteristics of human atherectomy tissue from coronary and lower extremity arterial stenoses. Am J Cardiol 77 (1996) 468-474
10. O'Brien E.R., Alpers C.E., Stewart D.K., Ferguson M., Tran N., Gordon D., et al. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 73 (1993) 223-231
11. Glover C., Ma X., Chen Y.-X., Miller H., Veinot J., Labinaz M., et al. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 144 (2002) 702-709
12. Marek J.M., Koehler C., Aguirre M.L., Westerband A., Gentile A.T., Mills J.L., et al. The histologic characteristics of primary and restenotic carotid plaque. J Surg Res 74 (1998) 27-33
13. Skowasch D., Jabs A., AndriÈ R., Dinkelbach S., Schiele T.M., Wernert N., et al. Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. J Vasc Res 41 (2004) 525-534
14. Pickering J., Weir L., Jekanowski J., Kearney M., and Isner J. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 91 (1993) 1469-1480
15. Kearney M., Pieczek A., Haley L., Losordo D.W., Andres V., Schainfeld R., et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 95 (1997) 1998-2002
16. McCaffrey T.A., Du B., Fu C., Bray P.J., Sanborn T.A., Deutsch E., et al. The expression of TGF-β receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor Imbalance. J Mol Cell Cardiol 31 (1999) 1627-1642
17. Kobayashi K., Yokote K., Fujimoto M., Yamashita K., Sakamoto A., Kitahara M., et al. Targeted disruption of TGF-β-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury. Circ Res 96 (2005) 904-912
18. Miyazawa K., Shinozaki M., Hara T., Furuya T., and Miyazono K. Two major Smad pathways in TGF-β superfamily signalling. Genes Cell 7 (2002) 1191-1204
19. Hollenbeck S.T., Sakakibara K., Faries P.L., Workhu B., Liu B., and Kent K.C. Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway. J Surg Res 120 (2004) 288-294
20. Liu B., Itoh H., Louie O., Kubota K., and Kent K.C. The signaling protein Rho is necessary for vascular smooth muscle migration and survival but not for proliferation. Surgery 132 (2002) 317-325
21. Furukawa Y., Matsumori A., Ohashi N., Shioi T., Ono K., Harada A., et al. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circulation research 84 (1999) 306-314
22. Roque M., Kim W.J., Gazdoin M., Malik A., Reis E.D., Fallon J.T., et al. CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol 22 (2002) 554-559
23. O'Brien E.R., Urieli-Shoval S., Garvin M.R., Stewart D.K., Hinohara T., Simpson J.B., et al. Replication in restenotic atherectomy tissue. Atherosclerosis 152 (2000) 117-126
24. Isner J.M., Kearney M., Bortman S., and Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 91 (1995) 2703-2711
25. Höfling B., Welsch U., Heimerl J., Gonschior P., and Bauriedel G. Analysis of atherectomy specimens. Am J Cardiol 72 (1993) 96E-107E
26. Schwartz R.S., Chu A., Edwards W.D., Srivatsa S.S., Simari R.D., Isner J.M., et al. A proliferation analysis of arterial neointimal hyperplasia: lessons for antiproliferative restenosis therapies. Int J Cardiol 53 (1996) 71-80
27. Tepe G. Drug-eluting stents for infrainguinal occlusive disease: progress and challenges. Semin Vasc Surg 19 (2006) 102-108
28. Smith J.D., Bryant S.R., Couper L.L., Vary C.P., Gotwals P.J., Koteliansky V.E., et al. Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. Circ Res 84 (1999) 1212-1222
29. Ryer E.J., Hom R.P., Sakakibara K., Nakayama K.I., Nakayama K., Faries P.L., et al. PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells. Arterioscler Thromb Vascular Biol 26 (2006) 780-786